Professor of Medicine, University Miami School of Medicine
Allergy & Immunology
Dr. Margaret A. Fischl, MD
|
|
Give Review
Doctor Margaret A. Fischl, MD practices Allergy & Immunology. She went to medical school at University of Miami Miller School of Medicine. University of Miami Miller School of Medicine is ranked 45 in research and 0 in primary care medicine She has 1 awards "Super Doctor". Margaret Fischl has written publications. She has 27 publications published with PubMed. The lastest paper is: 'A therapeutic HIV-1 vaccine enhances anti-HIV-1 immune responses in patients under highly active antiretroviral therapy.'
Publications
- Loss of Intra-Epithelial Endocervical Gamma Delta (GD) 1 T Cells in HIV-Infected Women.
- Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test.
- Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202.
- Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine.
- Racial Differences in Response to Antiretroviral Therapy for HIV Infection: An AIDS Clinical Trials Group (ACTG) Study Analysis.
- Combination antiretroviral therapy with Raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection.
- Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.
- HIV-1 Amino Acid Changes Among Participants With Virologic Failure: Associations With First-line Efavirenz or Atazanavir Plus Ritonavir and Disease Status.
- Therapeutic Drug Monitoring of Protease Inhibitors and Efavirenz in HIV-Infected Individuals With Active Substance-Related Disorders.
- Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients.
- Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive...
- The challenge of HIV-1 genetic diversity: discordant CD4+ T-Cell count and viral load in an untreated patient infected with a subtype F strain.
- Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults.
- Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir.
- Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug moni...
- Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application.
- Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial.
- Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.
- Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 disease.
- Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults.
- Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.
- Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500...
- A cross-sectional study of bacterial vaginosis, intravaginal practices and HIV genital shedding; implications for HIV transmission and women's health.
- Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202.
- Impaired Antibody Response to Influenza Vaccine in HIV-Infected and Uninfected Aging Women Is Associated with Immune Activation and Inflammation.
- A therapeutic HIV-1 vaccine enhances anti-HIV-1 immune responses in patients under highly active antiretroviral therapy.
Schools
University of Miami School of Medicine
University Miami Affil Hosps
University Miami
Doctors Specialties
- Internal Medicine
- Allergy
- Immunology
Accepted Insurances
Awards
- Super Doctor
Education
-
Jackson Memorial Hospital - Jackson Health System -
University of Miami Miller School of Medicine
Hospital
-
University of Miami Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Morris Beck, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren M. Fine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maureen E. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ileana M. Rodicio, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gabriel Costa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fernando Canada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Viviana M. Temino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marco L. Gonzalez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alina A. Campos-Vega, MD |
|
|
Dr. Lauren M. Fine, MD
This Doctor is OpenDoctor Recommended.
|